Proactive Investors - Run By Investors For Investors

Oxford Endovascular in GLP phase with its brain aneurysm treatment device

Oxford Endovascular Limited CEO Mike Karim spoke with Proactive Investors at the Biotech Showcase in San Francisco.

Oxford Endovascular Limited is a spin out from The University of Oxford. The company is developing metallic mesh tube devices invented by engineers and clinicians at the University to treat patients suffering from brain aneurysms.

View full OXFOR profile View Profile

Oxford Endovascular Ltd Timeline

Copyright ©, 2019. All Rights Reserved - Proactive Investors North America Inc., Proactive Investors LLC

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use